While studies assessing the toxicity of environmental contaminants to aquatic organisms date back to the early 1900s, the use of toxicity testing as a tool for monitoring the environmental acceptability of discharges from wastewater treatment and manufacturing facilities to surface waters (i.e., rivers, lakes, and oceans) did not begin to evolve until the 1970s. One of the primary motivating factors behind the development of biological monitoring, or biomonitoring, was the manufacture of exponentially increasing numbers of new chemicals for which analytical procedures were generally lacking. Biomonitoring was viewed as an approach to detect the presence of potentially toxic chemicals in facility discharges without necessarily having to identify the contaminants at that stage of the assessment. Additional advantages included the reduced expense associated with biologically testing significantly greater numbers of samples in comparison with analytical procedures. This approach also focused on only biologically available forms of the chemicals in solution reflecting any interactive effects (synergistic or antagonistic) that might be occurring among contaminants within a complex sample.